Topic: Institute for Cellular and Molecular Biology

Developing New Vaccines for Emerging Diseases is Focus of $6.5 Million Contract

Oct. 22, 2012

Accelerating the evaluation and development of new vaccines for emerging health threats is the goal of University of Texas at Austin researchers who recently received $6.5 million from the U.S. Department of Defense and the Defense Threat Reduction Agency.

Read more

Ancient Enzymes Function like Nanopistons to Unwind RNA

Sept. 2, 2012

The research found that DEAD-box proteins, which are ancient enzymes found in all forms of life, function as recycling "nanopistons."

Read more

Common Antifungal Drug Decreases Tumor Growth and Shows Promise as Cancer Therapy

Aug. 21, 2012

An inexpensive antifungal drug, thiabendazole, slows tumor growth and shows promise as a chemotherapy for cancer. Scientists in the College of Natural Sciences at The University of Texas at Austin made this discovery by exploiting the evolutionary relatedness of yeast, frogs, mice and humans.

Read more

Discovery of Why Influenza B Virus Exclusively Infects Humans Opens Door for Drugs to Fight Seasonal Epidemics Caused by Virus

Aug. 26, 2011

The three-dimensional structure of a site on an influenza B virus protein that suppresses human defenses to infection has been determined by researchers at Rutgers University and The University of Texas at Austin.

Read more

The dangers of cannibalism

July 14, 2011
The dangers of cannibalism

Biochemistry Professor Andy Ellington writes about cannibalism, prions, mad cow disease and yet one more way in which civilization may be "hosed."

Read more